FDA, suicidal thoughts
Digest more
The FDA is weighing a change that could make warning labels on dietary supplements appear less often on packaging.
The U.S. health regulator asked drugmakers on Tuesday to remove warnings about a potential ​risk of suicidal thoughts from widely used GLP-1 weight-loss drugs, including Novo Nordisk's Wegovy and Eli ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback